sq-11725 has been researched along with Recrudescence in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Belli, G; Brambilla, A; Capponi, G; De Simone, L; Favilli, S; Giovannini, M; Porcedda, G; Remaschi, G; Vannuccini, F | 1 |
| Chan, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL | 1 |
| Lock, G; Messmann, H; Wiest, R | 1 |
| Flevari, P; Kremastinos, DT; Livanis, EG; Mesiskli, T; Theodorakis, GN; Zarvalis, E | 1 |
| Barkin, JS; Maldonado, D | 1 |
| Chen, MH; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Lin, CP; Lo, CC; Lo, GH | 1 |
| Gawrieh, S; Saeian, K | 1 |
| Brullet, E; de la Peña, J; Garcia Suárez, C; Martin-Lorente, JL; Rivero, M; Sanchez-Hernández, E; Vergara, M | 1 |
| Chang, MS; Chiang, BN; Lin, SL; Liu, PH; Sung, RJ; Tai, TY | 1 |
| Khvoĭnitskiĭ, VA; Ostapiuk, FE | 1 |
| Buxton, AE; Josephson, ME; Lerman, BB; Sweeney, M; Waxman, HL | 1 |
| Balanzó, J; González, D; Martínez, FJ; Sáinz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
| Balanzó, J; Cussó, X; Guarner, C; Novella, MT; Sáinz, S; Soriano, G; Torras, X; Vilardell, F; Villanueva, C | 1 |
| Chambliss, ML; Stevermer, JJ | 1 |
| Dowdell, KC; Gienapp, IE; Stuckman, S; Wardrop, RM; Whitacre, CC | 1 |
| Zimmers, T | 1 |
| Bosch, J | 1 |
| Blendis, L; Wong, F | 1 |
| Elks, ML | 1 |
| Bedogni, G; Beltrami, M; Bertoni, G; Castagnetti, E; Conigliaro, R; Fornaciari, G; Grazia Mortilla, M; Plancher, AC; Ricci, E | 1 |
| Aliot, E; Clémenty, J; Hermida, JS; Leclercq, JF; Leenhardt, A; Lemarec, H; Sebag, C | 1 |
| Angeli, P; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D; Zuin, R | 1 |
1 review(s) available for sq-11725 and Recrudescence
| Article | Year |
|---|---|
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
9 trial(s) available for sq-11725 and Recrudescence
| Article | Year |
|---|---|
A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.
Topics: Adrenergic beta-Antagonists; Chi-Square Distribution; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Proportional Hazards Models; Recurrence; Treatment Outcome; Vasodilator Agents | 2009 |
Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
Topics: Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Female; Follow-Up Studies; Humans; Male; Nadolol; Propranolol; Prospective Studies; Recurrence; Syncope, Vasovagal; Treatment Outcome | 2002 |
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal and Gastric Varices; Esophagoscopy; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Nadolol; Probability; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Nadolol; Prospective Studies; Recurrence | 2005 |
[Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Coronary Disease; Humans; Hypertension; Middle Aged; Myocardial Infarction; Nadolol; Propanolamines; Propranolol; Recurrence | 1984 |
[Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging].
Topics: Adult; Aged; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Prospective Studies; Recurrence; Sclerotherapy | 1994 |
Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nadolol; Recurrence; Sclerotherapy; Survival Analysis; Treatment Outcome; Vasodilator Agents | 1996 |
Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study.
Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Pilot Projects; Random Allocation; Recurrence; Sclerotherapy | 1990 |
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial.
Topics: Adult; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nadolol; Random Allocation; Recurrence | 1987 |
12 other study(ies) available for sq-11725 and Recrudescence
| Article | Year |
|---|---|
Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.
Topics: Action Potentials; Adrenergic beta-Antagonists; Age Factors; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Female; Flecainide; Heart Rate; Humans; Infant; Infant, Newborn; Male; Nadolol; Recurrence; Retrospective Studies; Sotalol; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2021 |
[Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding].
Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Randomized Controlled Trials as Topic; Recurrence | 2002 |
Combined therapy for secondary prophylaxis of variceal rebleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Postoperative Complications; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Vasodilator Agents | 2002 |
Management of esophageal varices: an update from Digestive Disease Week and American Association for the Study of Liver Diseases 2003.
Topics: Adrenergic beta-Antagonists; Disease Progression; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Ligation; Nadolol; Recurrence | 2004 |
Nadolol and supraventricular tachycardia: an electrophysiologic study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Catheterization; Drug Evaluation; Electrocardiography; Female; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Recurrence; Tachycardia, Paroxysmal | 1983 |
Tachyarrhythmias associated with programmable automatic atrial antitachycardia pacemakers.
Topics: Adult; Electrophysiology; Female; Humans; Monitoring, Physiologic; Nadolol; Pacemaker, Artificial; Propanolamines; Recurrence; Software; Tachycardia; Verapamil | 1983 |
Prevention of variceal rebleeding.
Topics: Acute Disease; Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Combinations; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Sclerotherapy; Treatment Outcome | 1996 |
Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axis.
Topics: Adrenergic beta-Antagonists; Aminoglutethimide; Animals; Anti-Inflammatory Agents; Corticosterone; Encephalomyelitis, Autoimmune, Experimental; Epinephrine; Hormone Antagonists; Hypothalamo-Hypophyseal System; Interferon-gamma; Interleukin-2; Male; Mice; Mifepristone; Nadolol; Norepinephrine; Pituitary-Adrenal System; Recurrence; Time Factors | 1999 |
Cases in electrocardiography.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Diltiazem; Electrocardiography; Emergency Treatment; Female; Heart Block; Humans; Male; Multiple Trauma; Nadolol; Pain; Recurrence | 2000 |
Prevention of varices rebleeding: are drugs better after all?
Topics: Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide; Nadolol; Recurrence | 2002 |
Pseudohypoglycemia in adult victims of adolescent incest.
Topics: Adolescent; Anxiety Disorders; Blood Glucose; Child Abuse, Sexual; Female; Glucose Tolerance Test; Humans; Hypoglycemia; Incest; Middle Aged; Nadolol; Recurrence; Time Factors | 1990 |
Predictive value of electrophysiologic studies during treatment of ventricular tachycardia with the beta-blocking agent nadolol. The Working Group on Arrhythmias of the French Society of Cardiology.
Topics: Adult; Electrophysiology; Female; Humans; Male; Middle Aged; Nadolol; Predictive Value of Tests; Prospective Studies; Recurrence; Stroke Volume; Tachycardia | 1990 |